Deal snapshot: FOUR US COMPANIES MERGE TO FORM DISCOVERY LIFE SCIENCES.
US-based life science companies Conversant Bio, Folio Bio, Discovery Life Sciences and Phylogeny have merged under the name Discovery Life Sciences (Discovery) to create a global firm in biospecimen analysis and procurement for the pharmaceutical, biotechnology and diagnostics industries, the companies said.
The new company will leverage deep scientific expertise and consultative services, combined with the largest repository of more than 10m research-quality biospecimens, all available and processed for analysisa[euro]"to accelerate the discovery, research, and development of novel biomarkers, drug candidates, and diagnostics.
Target: Discovery Life Sciences
Buyer: Conversant Bio, Folio Bio, Discovery Life Sciences and Phylogeny
Deal size in USD:
Buyer advisor: , ,
Comment: Terms of the deal were not disclosed
|Printer friendly Cite/link Email Feedback|
|Publication:||M & A Navigator|
|Date:||Oct 17, 2018|
|Previous Article:||Deal snapshot: GENERATIONAL EQUITY ADVISES PRESTIGE PROPERTY MAINTENANCE IN SALE TO JUNIPER LANDSCAPING.|
|Next Article:||Deal snapshot: CYBER CONSULTING AND INCIDENT RESPONSE FIRM SVGNIA TO BE ACQUIRED BY SINGAPORE'S TEMASEK.|